Olli Kampman
olli.kampman@utu.fi |
- Psykoosilääkkeet (2026) Psykiatria Partonen, Timo; Raaska, Kari; Kampman, Olli; Lönnqvist, Jouko
- Psyykenlääkkeiden kliininen käyttö (2026) Psykiatria Partonen, Timo; Raaska, Kari; Kampman, Olli; Lönnqvist, Jouko
- Amfetamiinipsykoosi - riskitekijät, ennuste ja hoitolinjaukset (2025)
- Duodecim
- IL-8 and IL-1RA serum levels predicting depression treatment response in 6-week follow-up (2025)
- Acta Neuropsychiatrica
- Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone users (2025)
- Acta Neuropsychiatrica
- Meta-analyses of clozapine, norclozapine levels and their ratio across three genome wide association studies (2025)
- Translational Psychiatry
- Sleep and schizophrenia polygenic scores in non-affective and affective psychotic disorders (2025)
- Psychological Medicine
- Socioeconomic status, antidepressant use, and return to work after disability due to common mental disorders (2025)
- European Psychiatry
- Suicidal acts and thoughts among persons with psychotic disorders in the Finnish SUPER study (2025)
- European Psychiatry
- Toimintamallin muutos poisti psykiatrian jonot Pohjanmaalla (2025)
- Lääkärilehti



